​

Elutia (ELUT) Revenue & Revenue Breakdown

OverviewForecastFinancialsChartTranscripts

Elutia Revenue Highlights

Latest Revenue (Y)

$24.38M

Latest Revenue (Q)

$6.03M

Main Segment (Y)

Women's Health

Elutia Revenue by Period

Elutia Revenue by Year

DateRevenueChange
2024-12-31$24.38M-1.50%
2023-12-31$24.75M3.76%
2022-12-31$23.85M-49.68%
2021-12-31$47.39M11.03%
2020-12-31$42.68M-0.51%
2019-12-31$42.90M9.90%
2018-12-31$39.04M-

Elutia generated $24.38M in revenue during NA 2024, up -1.50% compared to the previous quarter, and up 56.82% compared to the same period a year ago.

Elutia Revenue by Quarter

DateRevenueChange
2025-03-31$6.03M10.28%
2024-12-31$5.47M-7.67%
2024-09-30$5.92M-5.87%
2024-06-30$6.29M-6.02%
2024-03-31$6.69M13.94%
2023-12-31$5.88M-4.11%
2023-09-30$6.13M-40.49%
2023-06-30$10.30M-21.10%
2023-03-31$13.05M3.04%
2022-12-31$12.66M2.23%
2022-09-30$12.39M-1.97%
2022-06-30$12.64M9.94%
2022-03-31$11.49M5.84%
2021-12-31$10.86M-5.43%
2021-09-30$11.48M-

Elutia generated $6.03M in revenue during Q1 2025, up 10.28% compared to the previous quarter, and up 102.64% compared to the same period a year ago.

Elutia Revenue Breakdown

Elutia Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
Women's Health$11.55M
Cardiovascular$2.92M

Elutia's latest annual revenue breakdown by segment (product or service), as of Dec 24: Women's Health (79.85%), and Cardiovascular (20.15%).

Quarterly Revenue by Product

Product/ServiceJun 25Mar 25Dec 24Sep 24Jun 24
Cardiovascular$736.00K$326.00K$1.27M$562.00K$1.08M
Women's Health$2.01M$2.63M$5.88M$3.10M$2.57M

Elutia's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Women's Health (73.21%), and Cardiovascular (26.79%).

Elutia Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ELUTElutia$24.38M$6.03M
LVTXLAVA Therapeutics$11.98M-
VRCAVerrica Pharmaceuticals$7.57M$12.70M
XLOXilio Therapeutics$6.34M$1.72M
DYAIDyadic$3.50M$393.57K
PLURPluri$1.34M$185.00K
RNXTRenovoRx$43.00K$197.00K
OKUROnKure Therapeutics--
RVPHReviva Pharmaceuticals--
MURAMural Oncology--
RANIRani Therapeutics--

ELUT Revenue FAQ

What is Elutia’s yearly revenue?

Elutia's yearly revenue for 2024 was $24.38M, representing a decrease of -1.50% compared to 2023. The company's yearly revenue for 2023 was $24.74M, representing an increase of 3.76% compared to 2022. ELUT's yearly revenue for 2022 was $23.85M, representing a decrease of -49.68% compared to 2021.

What is Elutia’s quarterly revenue?

Elutia's quarterly revenue for Q1 2025 was $6.03M, a 10.28% increase from the previous quarter (Q4 2024), and a -9.92% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $5.47M, a -7.67% decrease from the previous quarter (Q3 2024), and a -6.93% decrease year-over-year (Q4 2023). ELUT's quarterly revenue for Q3 2024 was $5.92M, a -5.87% decrease from the previous quarter (Q2 2024), and a -3.35% decrease year-over-year (Q3 2023).

What is Elutia’s revenue growth rate?

Elutia's revenue growth rate for the last 3 years (2022-2024) was 2.21%, and for the last 5 years (2020-2024) was -42.89%.

What are Elutia’s revenue streams?

Elutia's revenue streams in c 24 are Women's Health, and Cardiovascular. Women's Health generated $11.55M in revenue, accounting 79.85% of the company's total revenue Cardiovascular generated $2.92M in revenue, accounting 20.15% of the company's total revenue

What is Elutia’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Elutia was Women's Health. This segment made a revenue of $11.55M, representing 79.85% of the company's total revenue.